Precision immunotherapy for cancer treatment: understanding resistance to therapy, improving patients selection, and designing novel therapeutic strategies

Precision immunotherapy for cancer treatment: understanding resistance to therapy, improving patients selection, and designing novel therapeutic strategies

Stato

aperto

Copertura

Nazionale

Tipologia

Ricerca di base/clinica

Ruolo di capofila/partner

Partner

Ente finanziatore

Ministero della Salute

Principal Investigator

Prof. Antonio Rosato

Anno di finanziamento

2019
Scroll to Top